Article Details
Retrieved on: 2021-06-16 11:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
MacroGenics (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal-antibody-based ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here